HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2

Conditions

column CHIROBIOTIC V2, 25 cm x 4.6 mm I.D., 5 µm particles (15024AST)
column temp. 25 °C
mobile phase 15 mM ammonium formate in methanol
flow rate 1 mL/min
sample 1 mg/mL in methanol
injection 10 µL
detector UV, 230 nm

Description

Analysis Note Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The ® enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V2 successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.
Categories Analytical Chromatography, Chiral Applications, Antiobesity Drugs, Pharmaceutical (small molecule), All Pharmaceutical Applications
Featured Industry Pharmaceutical (small molecule)
Legal Information CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC, Astec is a registered trademark of Sigma-Aldrich Co. LLC
suitability application for HPLC

Materials

     
Related Links